SARS-CoV-2 Nucleocapsid Antibody | 10-065

SARS-CoV-2 Nucleocapsid Antibody | 10-065 | Gentaur UK, US & Europe Distribution

Host: N/A

Reactivity: Virus

Homology: N/A

Immunogen: Recombinant nucleoprotein of SARS-CoV (severe acute respiratory syndrome) .The nucleocapsid protein is expressed in the internal nucleocapsid of SARS-CoV-2.

Research Area: Infectious Disease, COVID-19

Tested Application: E, WB, IHC

Application: ELISA, IHC, WB (Quality Tested by ProSci) ; FC (Other applications as reported in literature)

Specificiy: Anti-SARS-CoV-2 Nucleocapsid, clone 1C7C7, specifically targets an epitope on the SARS-CoV-2 and SARS-CoV nucleocapsid protein. This antibody does not cross-react with the nucleocapsid of other common human coronaviruses, OC43 and 229E

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: >95% by SDS Page

Clonality: Recombinant Monoclonal

Clone: 1C7C7

Isotype: Mouse IgG2a

Conjugate: Unconjugated

Physical State: Liquid

Buffer: This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium, calcium or preservatives added.

Concentration: >1.0 mg/ml

Storage Condition: Functional grade preclinical antibodies may be stored sterile as received at 2-8˚ C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80˚ C. Avoid Repeated Freeze Thaw Cycles.

Alternate Name: SARS-CoV-2 Nucleocapsid, SARS-CoV-2 Nucleoprotein, Protein N, SARS-CoV N Protein

User Note: 43740575

BACKGROUND: N/A